Literature DB >> 21577249

Feasibility Assessment of Micro-Electrode Chip Assay as a Method of Detecting Neurotoxicity in vitro.

Enrico Defranchi1, Antonio Novellino, Maurice Whelan, Sandra Vogel, Tzutzuy Ramirez, Ben van Ravenzwaay, Robert Landsiedel.   

Abstract

Detection and characterization of chemically induced toxic effects in the nervous system represent a challenge for the hazard assessment of chemicals. In vivo, neurotoxicological assessments exploit the fact that the activity of neurons in the central and peripheral nervous system has functional consequences. And so far, no in vitro method for evaluating the neurotoxic hazard has yet been validated and accepted for regulatory purpose. The micro-electrode array (MEA) assay consists of a culture chamber into which an integrated array of micro-electrodes is capable of measuring extracellular electrophysiology (spikes and bursts) from electro-active tissues. A wide variety of electrically excitable biological tissues may be placed onto the chips including primary cultures of nervous system tissue. Recordings from this type of in vitro cultured system are non-invasive, give label free evaluations and provide a higher throughput than conventional electrophysiological techniques. In this paper, 20 substances were tested in a blinded study for their toxicity and dose-response curves were obtained from fetal rat cortical neuronal networks coupled to MEAs. The experimental procedure consisted of evaluating the firing activity (spiking rate) and modification/reduction in response to chemical administration. Native/reference activity, 30 min of activity recording per dilution, plus the recovery points (after 24 h) were recorded. The preliminary data, using a set of chemicals with different mode-of-actions (13 known to be neurotoxic, 2 non-neuroactive and not toxic, and 5 non-neuroactive but toxic) show good predictivity (sensitivity: 0.77; specificity: 0.86; accuracy: 0.85). Thus, the MEA with a neuronal network has the potency to become an effective tool to evaluate the neurotoxicity of substances in vitro.

Entities:  

Keywords:  chemical test; in vitro assay; micro-electrode array; neuronal networks; neurotoxicity

Year:  2011        PMID: 21577249      PMCID: PMC3088865          DOI: 10.3389/fneng.2011.00006

Source DB:  PubMed          Journal:  Front Neuroeng        ISSN: 1662-6443


Introduction

The determination of the toxicity profile of different chemical, biological, and pharmacological compounds is outlined in the current international testing guidelines (OECD, 1997; US EPA, 1998). An important element of the hazard assessment is the evaluation of potential neurotoxic effects (Crofton et al., 2004; Coecke et al., 2006). An agent is considered neurotoxic if an alteration in the structure or function in any part of the central and/or peripheral nervous system can be observed following acute or chronic exposure, at concentrations that do not affect general viability (Costa, 1998). A neurotoxic effect can be the direct alteration of the neurons structure or activity or can be the result of cascade effects due to glia activation and glia-neuron interactions; a neurotoxic effect can manifest immediately or delayed after the substance administration, it can be permanent or reversible, and it can affect the whole nervous system as well as parts of it (Monnet-Tschudi et al., 1997; Philbert et al., 2000; Tabakman et al., 2004; Coecke et al., 2006). Current directives for the evaluation of neurotoxic hazard (OECD, 1997; US EPA, 1998) are based on in vivo studies assessing neurophysiological, neuropathological, neurobehavioral, and neurochemical endpoints (Johnstone et al., 2010). These methods are expensive and time consuming, have a low throughput, and involve the use of a larger amount of test substances and animals. The need efficient testing and recent directives on animal use for laboratory tests is pushing the development and validation of new testing strategies based on alternative methods (Hartung et al., 2003, 2004), in which the use of time, materials, and animals is reduced and refined or animal use is completely replaced (3R). To date, no in vitro method has been validated for the neurotoxicology assessment, and one of the recent and most promising tools for neurotoxicity assessment is the measurement of electrical activity using micro-electrode array (MEA) chips. This technique is recording whole neuronal ensembles as functional networks and provides more relevant physiological information than other methods for electrophysiology assessment, e.g., patch clamps. The MEA-based recordings testing techniques dates back to the early eighties (Gross et al., 1982) and the technology behind has been improved since then (Gross et al., 1993; Breckenridge et al., 1995; Potter, 2001). Today many different in vitro models can be studied by MEA-based systems such as hippocampus slices, primary mammalian dissociated cultures and stem cells. Mammalian neuronal networks cultured from different brain structures on MEA chips remain spontaneously active and stable for many months (Gross et al., 1982; Potter and DeMarse, 2001; Gramowski et al., 2004; Van Pelt et al., 2004a, b). Moreover, these models respond to neurotransmitters and their blockers in a similar way as the in vivo situation (Streit, 1993; Gramowski et al., 2000; Keefer et al., 2001a, b; Martinoia et al., 2005). Primary cultures grown on MEA chips have been used in many studies of pharmacological and toxicological responses, and acute neurotoxicity detection (Gross et al., 1997; Gramowski et al., 2000, 2006; Morefield et al., 2000; Keefer et al., 2001b; Pancrazio et al., 2003; Xia and Gross, 2003; Xia et al., 2003; Sundstrom et al., 2005; Parviz and Gross, 2007; van Vliet et al., 2007). A very recent review (Johnstone et al., 2010) describes the state of the art of MEA-based assays for neurotoxicity assessment. In this study, electrical activity measurements were evaluated to see whether they are a reliable, accurate, and robust endpoint for the detection of neurotoxicity and could be suitable for predictive purposes in the chemical industry. To this end, 20 substances were selected, blinded at BASF (Germany) and then sent to ETT (Italy) to perform the test. The substances were selected according to their neurotoxic effects in vivo: 13 substances known to be neuroactive, 2 non-neuroactive and non-toxic and 5 non-neuroactive but toxic.

Materials and Methods

Chemicals

For the study purpose 20 substances were selected at BASF ( Germany) and sent to ETT (Italy) to perform the blind test. Some substances were selected according to their already known effect; some others are completely new for the MEA-based system literature. A set of 20 chemicals with different mode-of-actions (2 non-neuroactive and not toxic, Table 1; 5 not neuroactive but toxic, Table 2; 13 known to be neurotoxic, Table 3 substances) was prepared for the blind test. In particular the following set was selected and labeled as follows: (S1) Ibuprofen (CAS#:15687-27-1), (S2) 1,2,4-Trichlorobenzene (CAS#: 120-82-1), (S3) Trimethyltin chloride (CAS#: 1066-45-1), (S4) (2,4-Dichlorophenoxy) acetic acid sodium salt (CAS#: 2702-72-9), (S5) p-Cresol (CAS#: 106-44-5), (S6) Ethanol (CAS#: 64-17-5), (S7) Salicylic acid (CAS#: 69-72-7), (S8) Mepiquat chloride (CAS#: 24307-26-4), (S11) 1,2-Propandiol (CAS#: 57-55-6), (S13) Tetrahydroisoquinoline (THIQ; CAS#: 91-21-4), (S14) Toluene (CAS#: 108-88-3), (S15) Aniline (CAS#: 62-53-3), (S16) Nicotine (CAS#: 54-11-5), (S17) Fipronil (CAS#: 120068-37-3), (S19) Quinmerac (CAS#: 90717-03-6), (S20) Carbaryl (CAS#: 63-25-2), (S21) Nomifensine maleate salt (CAS#: 24526-64-5), (S22) Paraquat Dichloride (CAS#: 1910-42-5), (S23) Eugenol (CAS#: 97-53-0), (S24) Diphenhydramine hydrochloride (CAS#: 147-24-0). The 20 substances (12 powders and 8 liquids) were shipped in sealed amber glass vials labeled with numbers only (numbers from 1 to 24, 4 substances were omitted from the test). The set included 8 water soluble substances, and 12 water insoluble ones, which were diluted using DMSO. Each substance was dissolved to a 100-mM stock solution and then divided in aliquots stored at −20°C.
Table 1

Description and properties of the non-neuroactive and non-toxic substances utilized.

ChemicalLegal classification of acute oral toxicity in the European Union (ECB–JRC)1Description
1,2-Propandiol (S11)NO1,2-Propandiol is used an intermediate in the chemical industry, as a solvent in pharmaceuticals and as a food additive (E1520). In humans, pronounced toxicity was only observed at plasma concentrations above 1 g/L (about 13 mM; Flanagan et al., 1995)
Quinmerac (S19)NOQuinmerac is a quinoline carboxylic acid that is used as a systemic herbicide. It acts as a root growth inhibitor because it mimics the effects of supra optimal endogenous auxin concentrations (Grossmann et al., 2001). Quinmerac has a low acute systemic toxicity with an oral LD50 above 5000 mg/kg in rats2

1http://ecb.jrc.ec.europa.eu/esis/index.php?PGM=cla

2http://www.pesticides.gov.uk/PSD_PDFs/Evaluations/177_quinmerac.pdf

Table 2

Description and properties of the toxic but non-neuroactive substances utilized.

DescriptionLegal classificationDescription
Ibuprofen (S1)NOIbuprofen [2-(4-isobutylphenyl) propionic acid] is a non-steroidal anti-inflammatory drug (NSAID). It exerts its pharmacological action inhibiting the cyclooxygenase enzymes (COX). Overdoses may cause renal toxicity, hepatotoxicity but no neurotoxicity has been described (Nanau and Neuman, 2010)
(2,4-Dichlorophenoxy)acetic acid (S4)NO(2,4-Dichlorophenoxy)acetic acid is an herbicide. Target organs of mammalian toxicity are kidneys and liver but not the nervous system (Uyanikgil et al., 2009; Tayeb et al., 2010)
Salicylic acid (S7)NOSalycilic acid is known to inhibit cyclooxygenase. High doses of salicylate lead to a pyretic effect which is probably a direct result of the uncoupling of oxidative phosphorylation (Battaglia et al., 2005)An oral LD50 of 891 mg/kg body weight was reported for rats (BIOFAX Industrial Bio-Test Laboratories, Inc., Data Sheets. Vol. 21-3/1971)
Aniline (S15)Acutely toxic by inhalation, skin contact and oral uptake (H301, 311, 331)Aniline is an aromatic amine used as intermediate in the production of various chemicals. It is linked to the onset of methhemoglobinaemia (Gelpí et al., 2002)
Paraquat dichloride (S22)Acutely toxic by inhalation, skin contact and oral uptake (H301, 311, 331)Paraquat Dichloride is an herbicide. It is known to be toxic to humans, exerting acute effects by redox cycling generating intracellular oxidative stress in the lung (Dinis-Oliveira et al., 2008) Recently, chronic exposition to paraquat have been linked to the onset of neurotoxicity affecting dopaminergic system neurons (Ossowska et al., 2006; Thrash et al., 2007), these findings are still under discussion (Miller, 2007)
Table 3

Description and properties of the neurotoxic substances utilized.

DescriptionLegal classificationDescription
1,2,4-Trichlorobenzene (TCB; S2)Harmful if swallowed (H302)Rats and mice manifested symptoms of depressed activity at lower doses of TCB and extensor convulsions at lethal doses (IPCS, 1991). Tremors followed by death within 20–30 days occurred in monkeys exposed orally to 174 mg/kg/day (US EPA, 1994)
Trimethyltin chloride (S3)Fatal if inhaled, in contact with skin and if swallowed (H300, 310, 330)Trimethyltin chloride is a potent neurotoxic agent It produces lesions primarily in the limbic system, including those in the hippocampus, fascia dentata, pyriform cortex, entorhinal cortex, and amygdaloid nucleus (Brown et al., 1979; Bouldin et al., 1981; Chang et al., 1982; Dyer et al., 1982; Philbert et al., 2000)
p-Cresol (S5)Toxic in contact with skin and if swallowed (H301, 311)p-Cresol damages the CNS if inhaled (Kavitha and Palanivelu, 2005) by various toxic effects, like decreasing the response of activated polymorphonuclears, inhibition of platelet activating factor synthesis by human adherent monocytes and decrease of the endothelial cell response to inflammatory cytokines (D’Hooge et al., 2003; Schepers et al., 2007)
Ethanol (S6)NOEthanol stimulates the GABA-receptors in the nervous system and blocks the NMDA-receptors. Therefore, high amounts of ethanol leads to programmed cell death of the neuronal cells (Xia and Gross, 2003; Pohl-Guimaraes et al., 2010)
Mepiquat chloride (S8)Harmful if swallowed (H302)Mepiquat chloride is a plant growth regulator that inhibits the biosynthesis of gibberellic acidIn rats, mepiquat chloride had an acute oral LD50 of 464 mg/kg body weight. Additionally, in an acute oral neurotoxicity study in rats the NOAEL was 100 mg/kg body weight based on observations of decreased motor activity at doses of 300 mg/kg and above. The effect was attributed to reversible binding of mepiquat to nicotinic and muscarinic receptors (EFSA, 2008)
Tetrahydroisoquinoline (THIQ; S13)NOTetrahydroisoquinoline (THIQ) is a secondary aromatic amine. Used as intermediate and formed as a metabolite. It is structurally related to several neuroactive compounds Endogenous production of neurotoxic tetrahydroisoquinoline derivatives from certain drugs such as norsalsolinol is investigated as possible cause for neurological disease (Abe et al., 2005)
Toluene (S14)Toxic effects (H 361d, 304, 373, 315, 336) including (H336) induction of dizziness and drowsinessToluene is a volatile organic solvent, which is widely used in industry and a number of commercial products. It readily crosses the blood–brain barrier after inhalation and produces effects similar to that of sedative–hypnotics, such as alcohol and benzodiazepines (Balster, 1998). The mechanism has not yet been clarified. In chronic toluene abusers cerebellar dysfunction and cerebral and hippocampal atrophy as well as a loss of brain volume was found (Yamanouchi et al., 1995; Kamran and Bakshi, 1998; Deleu and Hanssens, 2000; Win-Shwe and Fujimaki, 2010)
Nicotine (S16)Toxic in contact with skin and if swallowed (H301, 310)Nicotine is an alkaloid naturally present in members of the Solanaceae family of plants. It acts as an agonist for nicotinic cholinergic receptors (nAChR), which is a non-selective cation channel. (Lindstro, 1997)
Fipronil (S17)Acute toxicity by inhalation, skin contact and if swallowed (H331, 311, 301).Fipronil is a phenylpyrazole and used as an insecticide and akaricide. It blocks the GABAa receptors (chloride-ion channel), which causes a hyper excitation of the parasite
Carbaryl (S20)Acute toxicity by inhalation and if swallowed (H332, 302)Carbaryl is a contact insecticide from the carbamate group. It acts on the CNS of insects by blocking the Acetylcholine esterase (AChE). This results in the enrichment of acetylcholine at the postsynaptic membrane which causes permanent agitation. The consequences are paralysis, apnoea, and eventually mortality (Gupta, 2006). In mammalian models, it elicited a marked hypothermia and reduction in motor activity in rats when administered orally at doses that inhibit brain AChE activity (Gordon et al., 2006)
Nomifensin maleate (S21)NONomifensin maleate had been used as an antidepressant and anesthetic because it blocks the dopamine reuptake in the brain at low levels (10 μM). It also induces hemolytic anemia and was therefore removed from the market. (Kinney, 1985; Nuwayhid and Werling, 2006; Obach and Dalvie, 2006)
Eugenol (S23)NOEugenol is used in dentistry as a local analgesic agent. The induced sedation and loss of consciousness in rats in a dose-dependent manner (Guenette et al., 2006). CNS depression was also reported with acute intoxication of humans (Lane et al., 1991)
Diphenhydramine hydrochloride (S24)NODiphenhydramine hydrochlorid is a first generation antihistamine, which can penetrate the blood–brain barrier. Like several other first generation antihistamines, it is also a potent competitive antagonist of muscarinic cholinergic receptors and furthermore is able to block the reuptake of serotonin (Sewell et al., 1985). Diphenhydramine causes sedation, due to its histamine H1 receptor antagonism.
Description and properties of the non-neuroactive and non-toxic substances utilized. 1http://ecb.jrc.ec.europa.eu/esis/index.php?PGM=cla 2http://www.pesticides.gov.uk/PSD_PDFs/Evaluations/177_quinmerac.pdf Description and properties of the toxic but non-neuroactive substances utilized. Description and properties of the neurotoxic substances utilized.

Cell culture

Three different rat strains, namely Wistar SPF, Sprague-Dawley, and CD SPF/VAF F were employed to prove the reliability of results on the same district from different animal sources. The primary cultures of cortical neurons were prepared from fetal day 18 rats according to previously described procedures (Chiappalone et al., 2006). Briefly, the cortex was dissociated through enzymatic and mechanical dissociation (0.125% Trypsin – DNAse I 0.025 mg/ml – BSA 0.3% solution in HBSS without calcium and magnesium). The cells were seeded on standard 60-electrode TiN-SiN MEA chips with internal reference (Multi Channel Systems, Reutlingen, Germany) pre-coated with poly-D-lysine and laminin (0.1 mg/ml diluted in sterile MilliQ water) as 50 μl droplets (1500–2000 cells/mm2), with subsequent addition of 1 ml of medium after the cells were attached (approximately 2 h). Cultures were maintained in neurobasal (NB) medium supplemented with 2% B27 and 1% Glutamax-I, and half volume of the medium was exchanged once a week. Cells were maintained at 37°C in a humidified atmosphere of 5% CO2 until their use.

Experimental layout

Experiments were carried from 25 to 54 days in vitro (DIV), when neuronal networks are mature (Novellino and Zaldívar, 2010). Each substance was tested at least three times and using neuronal networks from different neuronal isolations. Any neuronal network was used only once. In order to stabilize the culture condition, a 50% medium change was performed 48 h before testing. The day of the experiment the seven test dilutions (100 nM, 1 μM, 10 μM, 100 μM, 1 mM, 10 mM, 100 mM) were freshly made by diluting the thawed mother solution into the solvent (H2O or DMSO). The culture medium volume was checked to be 1 ml before any experimental session. Reagents were then introduced by the following pipetting procedure to ensure proper mixing: 200 μl of medium was removed from the medium bath covering the networks, mixed with a small volume (1 μl) of the reagent dilution and carefully returned to the medium bath in order to minimize any osmotic or hydrodynamic stress. In case of water as solvent additional 0.9 μL of DMSO was added to the culture medium at any administration in order to expose any neuronal network to the same amount of DMSO. Typically concentration–response relationships were determined in a cumulative manner, in which the concentration of drug present in the medium was increased in a stepwise method in log units. At least two recovery tests were performed for any substance after 24 h, in particular the medium was completely changed after the experiment, and MEA returned to the incubator for 24 h. The spontaneous activity was recorded for 30 min and compared to the activity recorded from the same culture the day before.

Data recordings and signal processing

Standard 60-electrode MEA chips (with 30 μm diameter electrodes, 200 μm inter-electrode spacing with/without an integrated reference electrode) were employed. The activity was recorded by the MEA1060 System from Multi Channel Systems (MCS GmbH, Reutlingen, Germany, http://www.multichannelsystems.com). The system also included a temperature controller (TC02, MCS GmbH) that allowed heating of the MEA chips and thus the medium from the bottom. During recordings, cells were kept at 37°C and in a controlled humid atmosphere (5% CO2, 20% O2 and N2) to buffer the supernatant pH (pH was 7.1 ± 0.1 during whole experiments). The MEA chips were placed into the MEA Amplifier (Gain 1000×) and data were recorded by the MC_Rack software at a sampling rate of 10 kHz. A band pass digital filter (60–4000 Hz) was applied to the raw signal in order to remove electrical background noise. Spike trains were extracted by the MC_Rack spike detection: if the electric signal overcomes the spike detection threshold (i.e., 6.0 ± 0.5 times the SD of the mean square root noise) the spike is identified and recorded. All analyses were conducted on binned data with bin size of 60 s. Data from experimental episodes were averaged for the last 20 min over the 30-min time window of recording for each concentration and the network mean firing rate (MFR) was extracted as a descriptor of the network activity level. Each time point of the experiment was the average of the firing rate over a 60-s time period. A stable level of spontaneous activity was required in order to start the experiment and was considered as the reference. In general, there is a transition period until equilibrium is achieved which has been established by each laboratory with post hoc analysis in previous experiments. The response during this transition time window has not been considered for the concentration–response analysis The percent change in firing rate at each concentration was then determined relative to the reference spontaneous activity period. To determine the changes of network activity with time, mean network spike rate of all active channels over the course of the whole experiment were considered. For the purpose of obtaining the IC50 values from the dose–response curve the changes in MFR were considered. Plots were also used to determine the concentration that stopped the activity completely.

Channel inclusion/exclusion criterion

Some simple rules were used for considering the neuronal network and its activity acceptable. The first criterion was based on the network morphology evaluation done by a trained and experienced operator. On a regular basis during the culture time and prior to MEA recording each chip was inspected under microscope to check for the neuronal network morphology and growth basing on the presence of a dense and uniform distribution of neuronal cells and the presence of neuronal connections on the recording area as previously described (Hogberg et al., 2011). The second criterion was based on the electrophysiological activity analysis, and both noisy and silent channels were excluded from the analysis. In particular during the reference activity if the spontaneous firing rate was lower than 10 spikes/bin (bin size of 60 s) the channel was considered a silent channel, and if the spontaneous firing rate was higher than 200 spikes/bin the channel was considered a noisy channel. The average of the excluded channel was 19.96 ± 0.77.

Single dose–response acceptance criteria

The aim of the investigation was to extract the mean effect of the chemical on the activity of the neuronal network once the interaction between the chemical and the neurons’ receptors had reached the saturation phase, the CVTIME of spike rate, i.e., the coefficient of variation of the spike rate in time, was studied to check the stability of the neuronal network activity after the chemical administration. The CV, in general calculated by CV = SD/mean, was used to describe the spatiotemporal behavior of the network activity (Keefer et al., 2001a; Gramowski et al., 2004) and the CVTIME quantify the spatiotemporal behavior reflecting temporal dynamics and the fundamental interactions within the networks. The CVTIME was extracted for each channel and the average of the CVTIME was used as a further exclusion criterion. If the CVTIME never reached and stabilized the 20% for more than one administration, the experiment was rejected. In average the CVTIME reached and stabilized down the threshold by 10 min after the chemical administration.

Statistical analysis

The Igor Pro 6.1 (Wavemetrics Inc., USA) program was used for statistical analyses. All data given are means of at least three independent experiments ± SEM. Student’s one tail paired t-test was performed to assess differences between basal spontaneous activity and activity after chemical administration. Statistical significance was indicated for P < 0.05. The averaged spike rate as a function of the concentration was fitted to both Hill Equation and Sigmoid Fitting tool for estimating the IC50 value. The predictivity parameters have been calculated according to the following formulae: Specificity = number of true negatives/number of true negatives + number of false positives Sensitivity = number of true positives/number of true positives + number of false negatives Accuracy = correct identified analytes (positives and negatives)/ total number of analytes.

Results

To assess the maturation of a neuronal network on MEA, the spontaneous activity of a MEA chip was measured every week. As already described (Van Pelt et al., 2005; Wagenaar et al., 2006; Hogberg et al., 2011), at the early time point (7 DIV) only a few of the cultures have shown spontaneous activity that was weak (few active channels and no synchronized pattern), then the activity increased over time and became more and more synchronized with the typical bursting and spiking pattern of cortical neuronal cultures at the age of 28 DIV. At the maturation time, i.e., after 4 week of in vitro culture, the neuronal networks exhibited spontaneous activity in their respective media, consistent with previously reported effects (Xia et al., 2003; Gramowski et al., 2004; Chiappalone et al., 2006; Shafer et al., 2008). Network spike rates ranged from (mean ± SEM) 55.06 ± 6.98  spikes/s (n = 60). During experiments any neuronal network was exposed to DMSO at a final concentration of 0.7%. In order to check the DMSO induced effects, control experiments were performed both with a one-step as well as with progressive administrations and no effects of DMSO on spontaneous activity were recorded (data not shown). The tested substances were supposed to fall in three main groups according their biological activities based on legal classification (EBC–JRC) and published in vivo and in vitro data, namely (1) not neuroactive and not toxic, (2) toxic but not neuroactive, and (3) neurotoxic substances. The results obtained are summarized in Table 4.
Table 4

Results of the blinded test of the 20 substances.

SubstanceToxicological classificationMFR excitationMFR reductionMFR total cessationEstimated IC50Recovery
QuinmeracA
1,2-PropandiolB
2,4-D sodium saltToxic but not neuroactiveA
IbuprofeneToxic but not neuroactiveB
Salicylic acidToxic but not neuroactiveB
Paraquat DichlorideToxic but not neuroactiveB
AnilineToxic but not neuroactivexB
NicotineNeuroactivexB
EthanolNeuroactiveA
TolueneNeuroactiveB
Mepiquat chlorideNeuroactiveB
1,2,4-TrichlorobenzeneNeuroactivex60 μMB
TetrahydroisoquinolineNeuroactivex20 μMB
p-Cresol (4-Methylphenol)Neuroactivex1–10 μMB
FipronilNeuroactivexx65–90 μMB
Carbaryl (1-Naphthylmethylcarbamat)Neuroactivexx25–65 μMA
Nomifensin maleate saltNeuroactivexx10–20 μMA
Diphenhydramine hydrochlorideNeuroactivexx5–20 μMB
EugenolNeuroactivexx3–7 μMC
Trimethyltin chlorideNeuroactivexx1–10 μMC

Resume of the results obtained for the tested substances, ordered following their toxicological classification (no toxicity, toxic but not neuroactive, or neuroactive) and their toxic potency. Effects on MFR are indicated, as well as the registered recovery (A: good recovery, B: average recovery, C: poor recovery), and a range for the estimated IC.

Results of the blinded test of the 20 substances. Resume of the results obtained for the tested substances, ordered following their toxicological classification (no toxicity, toxic but not neuroactive, or neuroactive) and their toxic potency. Effects on MFR are indicated, as well as the registered recovery (A: good recovery, B: average recovery, C: poor recovery), and a range for the estimated IC.

Not neuroactive and not toxic substances

In accordance to their in vivo data, these two substances had no significant effect on network activity (Figure 1). 1,2 Propandiol caused a slight increase in the firing rate at high concentrations, but this effect is not statistically significant.
Figure 1

Electrical activity effects on neuronal cultures after administration of not neuroactive and not toxic substances. Electrical activity following administration of substances classified in the not neuroactive and not toxic group (at the concentration indicated under the bars) has been recorded and normalized in respect to native activity (percent of control, indicated as 100 in the ordinate axis). All data are means of at least three independent experiments ± SEM. Student’s one tail paired t-test was performed to assess differences between basal spontaneous activity and activity after chemical administration. Statistical significance was indicated by * for P < 0.05.

Electrical activity effects on neuronal cultures after administration of not neuroactive and not toxic substances. Electrical activity following administration of substances classified in the not neuroactive and not toxic group (at the concentration indicated under the bars) has been recorded and normalized in respect to native activity (percent of control, indicated as 100 in the ordinate axis). All data are means of at least three independent experiments ± SEM. Student’s one tail paired t-test was performed to assess differences between basal spontaneous activity and activity after chemical administration. Statistical significance was indicated by * for P < 0.05.

Toxic but not neuroactive substances

The substances in this group had no significant effect on MFR, as expected, at the concentrations tested, with the exception of aniline that presented a mild but significant progressive increase in the MFR during the experiment (Figure 2).
Figure 2

Electrical activity effects on neuronal cultures after administration of toxic but not neuroactive substances. Electrical activity following administration of substances classified in the toxic but not neuroactive group (at the concentration indicated under the bars) has been recorded and normalized in respect to native activity (percent of control, indicated as 100 in the ordinate axis). All data are means of at least three independent experiments ± SEM. Student’s one tail paired t-test was performed to assess differences between basal spontaneous activity and activity after chemical administration. Statistical significance was indicated by * for P < 0.05.

Electrical activity effects on neuronal cultures after administration of toxic but not neuroactive substances. Electrical activity following administration of substances classified in the toxic but not neuroactive group (at the concentration indicated under the bars) has been recorded and normalized in respect to native activity (percent of control, indicated as 100 in the ordinate axis). All data are means of at least three independent experiments ± SEM. Student’s one tail paired t-test was performed to assess differences between basal spontaneous activity and activity after chemical administration. Statistical significance was indicated by * for P < 0.05.

Neuroactive substances

Nine of the thirteen substances in this group showed a significant effect on neuronal network activity (Figure 3). All the substances that caused an MFR reduction, or its total cessation, belongs to this group. Nicotine showed a slight increase in MFR at the maximum tested concentration. And three substances, namely ethanol, mepiquat, and toluene, did not show a significant effect.
Figure 3

Electrical activity effects on neuronal cultures after administration of neuroactive substances. Electrical activity following administration of substances classified in the neuroactive group (at the concentration indicated under the bars) has been recorded and normalized in respect to native activity (percent of control, indicated as 100 in the ordinate axis). All data are means of at least three independent experiments ± SEM. Student’s one tail paired t-test was performed to assess differences between basal spontaneous activity and activity after chemical administration. Statistical significance was indicated by * for P < 0.05.

Electrical activity effects on neuronal cultures after administration of neuroactive substances. Electrical activity following administration of substances classified in the neuroactive group (at the concentration indicated under the bars) has been recorded and normalized in respect to native activity (percent of control, indicated as 100 in the ordinate axis). All data are means of at least three independent experiments ± SEM. Student’s one tail paired t-test was performed to assess differences between basal spontaneous activity and activity after chemical administration. Statistical significance was indicated by * for P < 0.05.

Recovery tests

To have an indication about the reversibility of the effects of the substances utilized, a recovery test was performed after 24 h following a complete medium wash-out, and the electrical activity compared to the basal activity recorded on the same culture the day before. The recovery results were classified according to a three level scale: A – good recovery (level of activity more than 70% of the spontaneous activity recorded during the reference period the day before); B – average recovery (level of activity between 35 and 70%); C – poor recovery (recovered activity less than 35%). Five substances showed a good recovery (Table 4), and two of them [Carbaryl (S20) and Nomifensine (S21)] initially showed high neuroactivity, indicating the reversibility of their effects. TMT (S3) and Eugenol (S23) had a poor recovery, which indicates that there was a strong neuroactive effect that ended in cytotoxicity. For all the other substances the recovery was average.

Discussion

The problem of toxicity assessment of all chemicals sold in Europe according to the REACH regulation is particularly challenging: a recent research (Hartung and Rovida, 2009) presented a very critical situation. Industries are already facing the submission of existing toxicity data and animal-testing plans for part of the “old” chemicals because much information, such as reproductive toxicity, neurotoxicity, developmental neurotoxicity, etc., is missing. Current in vivo test methods are based on behavioral and sensory perturbations coupled with routine histopathological investigations. In spite of the empirical usefulness of these tests, they are not always sensitive enough, and often they do not provide information that facilitates a detailed understanding of potential mechanisms of toxicity, thus enabling predictions. Regarding the status of in vitro tests, they are generally not used to detect neurotoxicity for prediction of hazards to human health and so far they play a complementary role to the in vivo tests (Bal-Price et al., 2010). Furthermore, the current in vitro test methods are far from being capable of testing large numbers of chemicals in a short time. High throughput and high content screening (HTS/HTC) methods have been proposed as an integral component of future toxicity testing strategies (Costa, 1998; Coecke et al., 2006; Lein et al., 2007; NRC, 2007). However, they are often not designed to assess the physiology and functionality of living neurons, which may result in missing the effects of some chemicals and/or hamper the identification of toxicity pathways related to higher level functions of the nervous system. The set up and validation of an alternative in vitro method constitute therefore a topic of central interest in order to reduce, refine and replace animal-testing. So far, the MEA technique has been used in several pharmacological and toxicological studies (Gross et al., 1997; Gramowski et al., 2000,2006; Morefield et al., 2000; Keefer et al., 2001b; Sundstrom et al., 2005; Parviz and Gross, 2007; van Vliet et al., 2007) and the IC50 ranges have been established in the same range as those published for other toxicological studies and are in general in agreement with those obtained from animal experiments (Xia and Gross, 2003; Xia et al., 2003). However, until now MEAs were not tested as an in vitro model for neurotoxicity testing of large varieties of chemicals. Comparing the results from this study with neuronal network on MEA to published in vivo data, there were 10 substances identified as true positives, 1 as false positive, 6 true negative and 3 false negative. Based on these data the sensitivity of the assay was 77% and the specificity was 86%. This makes an overall accuracy of 80% for the assay.

Parameters extraction/Activity evaluation methods

Despite the large number of applications and studies related to the use of MEA-based systems, there are still a few universally accepted methodologies to extract information to assess neurotoxicity. While bursting behavior and bursting synchronization over active channels are important criteria for verifying the maturation of the in vitro neuronal network (i.e., quality of the activity), burst parameters such as mean bursting rate, burst duration, mean spikes in burst, etc., that were shown to provide important information for basic research (e.g., Wagenaar et al., 2006; Novellino et al., 2007), did not give any particular advantage for neurotoxicity assessment. As the burst parameters are extracted from spike trains the accuracy and reliability were mostly the same as the MFR (data not shown), while the computation time and complexity were higher. Available methods are based on spike detection algorithms that produce multi-site spike, which can be further analyzed for spike sorting, first and higher order statistics (e.g., burst analysis) and cross correlation based methods. A recent paper from Maccione et al. (2009) demonstrated that the accuracy of spike detection methods is quite comparable, and if the goal of the study is not the precise timing but rather the average effects on a large binning window (e.g., 1 min of activity) the computational requirement for accurate spike detection is not necessary since a simple spike threshold identification provides a simple yet sufficient method.

Effects of administered chemicals

The results of this blinded study consistently determined the effects for 20 chemicals based on the inhibition of spontaneous neuronal network activity (i.e., MFR at neuronal network level). Indeed, the estimated IC50 values for all 20 compounds were within less than one order of magnitude. This reproducibility, despite differences in sources of cells and age at recording, demonstrates the robustness of MEA approaches for neurotoxicity tests. For this investigation a wide range of concentrations have been explored, spanning through six orders of magnitude, from 100 pM to 100 μM. The lowest did not show significant activity variations, but have been useful to test the robustness of the system in regard to mechanical manipulation. Furthermore, given the sensibility of the system and the explorative nature of the study, it was considered useful to test a wide range of concentrations. The MEA-based paradigm can be very helpful for recognizing toxic and non-toxic compounds in a middle throughput screening assay. Although it is useful that the assay accurately and sensitively predict the toxic range of a substance, in case of chemical labeling and risk assessment the most important question is whether the chemical is toxic and which is the order of magnitude of the concentration in which it starts being toxic. Following this approach, the estimated IC50 are indicative of the order of magnitude of the registered effects in order to deal with the obtained results, and not meant to constitute a precise toxicological characterization of the analytes. Refinement of the employed conditions is surely required for a more precise and refined description of the action mechanism of the different substances. The tested substances were supposed to fall into three main groups according their biological activities based on legal classification (EBC–JRC) and published in vivo data, namely (1) non-neuroactive and non-toxic, (2) toxic but non-neuroactive and (3) neuroactive substances. The substances of the first two groups showed no detectable effect on neuronal activity in NN MEA, with the exception of Aniline, which caused a gradual increase in MFR. This represents the only false positive detected in this study. The slight increase in MFR registered following 1,2-Propandiol administration was not significant, and likely connected to unspecific effects. Regarding the 13 substances classified as neuroactive in vivo, the NN MEA assay registered nine substances causing a significant decrease of the MFR, one substance (nicotine) giving a significant increase at the highest concentration, and three substances, namely ethanol, mepiquat, and toluene, that showed no significant activity.

In vitro active neuroactive substances

All the MFR reductions registered in the present paper, either complete or partial, have been registered following the application substances belonging to this group.

Trimethyltin chloride

In agreement with its high neurotoxicity, trimethyltin chloride demonstrated the strongest action on cortical network activity between the tested chemicals. The registered behavior is in agreement with a previous study on MEAs reporting an EC50 of 4.3 μM for auditory cortex and 1.5 μM for spinal cord tissue derived from mouse embryonic tissue (Gramowski et al., 2000). Moreover, Kuramoto et al. (2011) showed in primary mouse cultures that trimethyltin toxicity is initially caused by activation of the caspase pathway in cortical neurons, which is in agreement with our recovery result, that show no reversible network activity on the next day.

Nicotine

In our experiment, nicotine showed an increase of the MFR at the highest tested concentration (100 μM). This result is apparently in contrast with its high potency in vivo. To date, the exact role of brain nAChRs is already a debated topic. In vivo, nicotine effects are variable depending on the subtype and density of the different nicotinic receptors existing in the distinct brain regions (Toledano et al., 2010). A high density of nicotine receptors is found in the thalamus, caudate nucleus, and substantia nigra (Paterson and Nordberg, 2000), composed by various homomeric or heteromeric combinations of 12 different subunits (Mansvelder et al., 2009). Their location in the brain is not limited to postsynaptic but also to pre-, peri-, and extra-synaptic sites where they may modulate neuronal function by a variety of actions (Lindstro, 1997). In particular, presynaptic nAChRs exist on several cell populations in cortical, hippocampal, and cerebellar brain regions (Wonnacott, 1997). Although a subset of nAChRs are postsynaptic located on a subset of GABAergic interneurons in cortical layer, nAChRs in cortex are mostly found on afferent terminals, in particular from thalamic neurons (Matherate, 2004), and consequently not present in cortical neuron preparations. This nAChRs distribution in the brain may explain the slight increase of activity at the highest concentration in NN MEA. In addition it suggests a need to consider different brain regions in NN MEA assays.

Fipronil

The initial excitatory effect is probably caused by the antagonist action on GABAa receptors, while the final inhibition might be due to a neurotoxic effect that affect the generation of spontaneous oscillatory activity of the network.

Eugenol

Eugenol showed, somehow unexpectedly, a rather strong neuroactive action. Eugenol’s effects on sensorial peripheral nerves have been studied, but there are few papers on its action on CNS. In a recent report, rat neocortical and hippocampal slices, eugenol (10–100 μM) showed inhibitory effects on elicited epileptiform discharges and potassium-induced spreading depression (Müller et al., 2006). Another study reported decreased population spikes amplitude in hippocampal slices (Ardjmand et al., 2006). The discussed findings are in accordance with our observation of a clear-cut inhibitory effect starting at 10 μM with almost complete cessation at 100 μM.

In vitro not-active neuroactive substances

As previously discussed, three substances belonging to the neuroactive group, showed no impairment of electrical activity in our experiment. Toluene, despite its well known neurotoxic actions, did not show any effect in our experiments (the slight decrease of activity at 100 pM is likely due to the mechanical manipulation rather than a true substance-related effect). Toluene volatility could have diminished its availability for the cultured neurons, even if after administration MEAs have been covered with semipermeable caps to avoid evaporation. Indeed, a transient decrease of network activity has been observed immediately after the administration of the maximum concentration, but disappeared a few minutes later (data not shown, personal observation of the experimenter). Regarding ethanol, it is worth noting that the maximum concentration of 100 μM in our tests equals a blood alcohol level of 0.005% which does not cause pronounced effects in humans. Accordingly, the lack of effects on neuronal network activity at lower concentrations has previously been reported; initial inhibition was only observed at 20 mM and total activity cessation at 100 mM (Xia and Gross, 2003). Also Mepiquat chloride had no effect on our experiments, even if neurotoxicity has been reported in in vivo studies. The first mild diminution in activity at the first tested concentration that results as statistically significant is probably due to mechanical manipulation. Interestingly, Mepiquat neuroactive effects are already in part mediated by nicotinic receptor binding (EFSA, 2008), and this could be a critical aspect to detect in cortical neurons network as discussed for nicotine effects. The evaluation of the effects on MFR after substance administration is certainly informative about neuronal activity, but is not a clear description for a neuroactive effect. A strong cytotoxic compound will end in a total cessation too, by measuring the electrical activity. Therefore it is important to test also cytotoxic markers to be able to distinguish between neuroactive and cytotoxic effects. We decided to investigate in a first experiment the recovery of the neuronal networks after a wash-out of the chemical substance as an indicator for cytotoxicity. Some of the substances showed absolutely no recovery (as shown, e.g., for TMT), the majority of substances showed a moderate recovery of activity, between 35 and 70%, which makes it difficult to distinguish between incomplete recovery, already present chemical agent, cytotoxic actions, or other effects related to manipulation. Multiple medium exchanges would be required to achieve a total wash-out, especially for water insoluble compounds, and together with different times of recovery before registration could help in generating more clear data. However, looking at a method to get information about the way of toxicity action of different substances, we propose that other endpoints could be more informative as an integration to electrophysiological measurements, such as the cytotoxicity assessment (for example by measuring the release of lactate dehydrogenase into the culture medium), or the evaluation of the metabolic state of the cells. The alterations of electrical activity induced by a compound’s application (functional neuroactivity) is indeed often not associated to cell death (cytotoxicity), or direct cellular physiology impairment. This is consistent with the acute neurotoxicity of many xenobiotics (e.g., ethanol, pyrethroids, tetrodotoxin, etc.) that cause the organism death prior to the onset of significant cytotoxicity in the nervous system. While not examined in these experiments, other studies (Novellino et al., 2011) showed that the compounds modified neuronal network activity in the absence of cytotoxicity. The evaluation of the previously mentioned endpoints could help in distinguishing between the different toxic effects.

Conclusion

For toxicological prediction of a compound, the detection and characterization of chemical-induced toxic effects in the central and peripheral nervous system represents a major challenge for employing newly developed technologies in the field of neurotoxicity (Dunlop et al., 2008). The use of neuronal cultures growing on MEAs innovates the field of neurotoxicity: a neuronal network coupled to MEA represents a simplified model of the nervous system in which the electric activity is measured in real-time while being exposed to tested substances. The presented feasibility study provides a further evidence of the potential use and usefulness of the proposed paradigm as an alternative method for gathering neurotoxicity information for chemical risk assessment, especially under a chemical industry perspective. So far the assay appears to be a reliable tool to exclude neuroactivity of chemicals in an early screening, and therefore we shall extend the evaluation of the NN MEA as a screening tool for the neurotoxic effects of chemicals.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
  81 in total

1.  Degeneration of dopaminergic mesocortical neurons and activation of compensatory processes induced by a long-term paraquat administration in rats: implications for Parkinson's disease.

Authors:  K Ossowska; M Smiałowska; K Kuter; J Wierońska; B Zieba; J Wardas; P Nowak; J Dabrowska; A Bortel; I Biedka; G Schulze; H Rommelspacher
Journal:  Neuroscience       Date:  2006-06-22       Impact factor: 3.590

Review 2.  Nicotinic modulation of synaptic transmission and plasticity in cortico-limbic circuits.

Authors:  Huibert D Mansvelder; Marjolijn Mertz; Lorna W Role
Journal:  Semin Cell Dev Biol       Date:  2009-01-22       Impact factor: 7.727

3.  Acute toxicity screening of novel AChE inhibitors using neuronal networks on microelectrode arrays.

Authors:  E W Keefer; S J Norton; N A Boyle; V Talesa; G W Gross
Journal:  Neurotoxicology       Date:  2001-02       Impact factor: 4.294

4.  Clove oil ingestion in an infant.

Authors:  B W Lane; M J Ellenhorn; T V Hulbert; M McCarron
Journal:  Hum Exp Toxicol       Date:  1991-07       Impact factor: 2.903

5.  Advantages of using microfabricated extracellular electrodes for in vitro neuronal recording.

Authors:  L J Breckenridge; R J Wilson; P Connolly; A S Curtis; J A Dow; S E Blackshaw; C D Wilkinson
Journal:  J Neurosci Res       Date:  1995-10-01       Impact factor: 4.164

6.  Quantification of acute neurotoxic effects of trimethyltin using neuronal networks cultured on microelectrode arrays.

Authors:  A Gramowski; D Schiffmann; G W Gross
Journal:  Neurotoxicology       Date:  2000-06       Impact factor: 4.294

7.  Trimethyltin initially activates the caspase 8/caspase 3 pathway for damaging the primary cultured cortical neurons derived from embryonic mice.

Authors:  Nobuyuki Kuramoto; Keiichi Seko; Chie Sugiyama; Makoto Shuto; Kiyokazu Ogita
Journal:  J Neurosci Res       Date:  2011-02-02       Impact factor: 4.164

8.  The value of alternative testing for neurotoxicity in the context of regulatory needs.

Authors:  Sandra Coecke; Chantra Eskes; Joanne Gartlon; Agnieszka Kinsner; Anna Price; Erwin van Vliet; Pilar Prieto; Monica Boveri; Susanne Bremer; Sarah Adler; Cristian Pellizzer; Albrecht Wendel; Thomas Hartung
Journal:  Environ Toxicol Pharmacol       Date:  2005-08-24       Impact factor: 4.860

9.  In vitro developmental neurotoxicity (DNT) testing: relevant models and endpoints.

Authors:  Anna K Bal-Price; Helena T Hogberg; Leonora Buzanska; Petros Lenas; Erwin van Vliet; Thomas Hartung
Journal:  Neurotoxicology       Date:  2009-12-05       Impact factor: 4.294

10.  Meeting report: alternatives for developmental neurotoxicity testing.

Authors:  Pamela Lein; Paul Locke; Alan Goldberg
Journal:  Environ Health Perspect       Date:  2007-01-29       Impact factor: 9.031

View more
  13 in total

1.  The Effects of Acute GABA Treatment on the Functional Connectivity and Network Topology of Cortical Cultures.

Authors:  Yao Han; Hong Li; Yiran Lang; Yuwei Zhao; Hongji Sun; Peng Zhang; Xuan Ma; Jiuqi Han; Qiyu Wang; Jin Zhou; Changyong Wang
Journal:  Neurochem Res       Date:  2017-03-13       Impact factor: 3.996

2.  Evaluation of multi-well microelectrode arrays for neurotoxicity screening using a chemical training set.

Authors:  Emma R McConnell; Maxine A McClain; James Ross; William R Lefew; Timothy J Shafer
Journal:  Neurotoxicology       Date:  2012-05-28       Impact factor: 4.294

3.  Application of stem cell derived neuronal cells to evaluate neurotoxic chemotherapy.

Authors:  Claudia Wing; Masaaki Komatsu; Shannon M Delaney; Matthew Krause; Heather E Wheeler; M Eileen Dolan
Journal:  Stem Cell Res       Date:  2017-06-15       Impact factor: 2.020

4.  Screening the ToxCast phase II libraries for alterations in network function using cortical neurons grown on multi-well microelectrode array (mwMEA) plates.

Authors:  Jenna D Strickland; Matthew T Martin; Ann M Richard; Keith A Houck; Timothy J Shafer
Journal:  Arch Toxicol       Date:  2017-08-02       Impact factor: 5.153

5.  Burst analysis tool for developing neuronal networks exhibiting highly varying action potential dynamics.

Authors:  Fikret E Kapucu; Jarno M A Tanskanen; Jarno E Mikkonen; Laura Ylä-Outinen; Susanna Narkilahti; Jari A K Hyttinen
Journal:  Front Comput Neurosci       Date:  2012-06-19       Impact factor: 2.380

6.  Effects of antiepileptic drugs on hippocampal neurons coupled to micro-electrode arrays.

Authors:  Ilaria Colombi; Sameehan Mahajani; Monica Frega; Laura Gasparini; Michela Chiappalone
Journal:  Front Neuroeng       Date:  2013-11-19

7.  916 MHz electromagnetic field exposure affects rat behavior and hippocampal neuronal discharge.

Authors:  Dongmei Hao; Lei Yang; Su Chen; Yonghao Tian; Shuicai Wu
Journal:  Neural Regen Res       Date:  2012-07-05       Impact factor: 5.135

8.  Ginkgo biloba L. (Ginkgoaceae) Leaf Extract Medications From Different Providers Exhibit Differential Functional Effects on Mouse Frontal Cortex Neuronal Networks.

Authors:  Benjamin M Bader; Konstantin Jügelt; Luise Schultz; Olaf H-U Schroeder
Journal:  Front Pharmacol       Date:  2018-08-03       Impact factor: 5.810

9.  ToolConnect: A Functional Connectivity Toolbox for In vitro Networks.

Authors:  Vito Paolo Pastore; Daniele Poli; Aleksandar Godjoski; Sergio Martinoia; Paolo Massobrio
Journal:  Front Neuroinform       Date:  2016-03-30       Impact factor: 4.081

10.  Green Toxicology: a strategy for sustainable chemical and material development.

Authors:  Sarah E Crawford; Thomas Hartung; Henner Hollert; Björn Mathes; Bennard van Ravenzwaay; Thomas Steger-Hartmann; Christoph Studer; Harald F Krug
Journal:  Environ Sci Eur       Date:  2017-04-04       Impact factor: 5.893

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.